BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 17550976)

  • 1. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
    Selvaraj NG; Omi E; Gibori G; Rao MC
    Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
    Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
    Han Y; Watling D; Rogers NC; Stark GR
    Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
    Sultan AS; Brim H; Sherif ZA
    Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
    Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
    Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
    García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
    Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK kinases overexpression promotes in vitro cell transformation.
    Knoops L; Hornakova T; Royer Y; Constantinescu SN; Renauld JC
    Oncogene; 2008 Mar; 27(11):1511-9. PubMed ID: 17873904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
    Linher-Melville K; Singh G
    BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
    Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Cho S; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
    Cell Signal; 2009 Jun; 21(6):892-8. PubMed ID: 19385051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
    Neradugomma NK; Subramaniam D; Tawfik OW; Goffin V; Kumar TR; Jensen RA; Anant S
    Carcinogenesis; 2014 Apr; 35(4):795-806. PubMed ID: 24265293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
    Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
    Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.